CLINICAL_TRIALS
trial_result
· 2015-05-21
Clinical Trial Update: Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension [Phase 4]
Summary
Phase 4 trial update evaluating the benefit of midodrine in neurogenic orthostatic hypotension has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Hypotension, Orthostatic | Phase 4 | Status: COMPLETED | Results posted: 2015-05-21